Home Search
animal health - search results
If you're not happy with the results, please do another search
Probiotics for poultry on the rise due to growing consumption of meat & egg
Driven by the rising demand for meat & egg consumption among global consumers, discover how and why the ingredients used in probiotics for poultry...
The guide to tackling common zoonotic diseases
What do you know about common zoonotic diseases? Such diseases continue to be a threat to global health, but FAO, OIE and WHO may...
SyrinJector takes livestock vaccination to the next level
SyrinJector introduces an innovative solution to the enormous challenge in the digital health of livestock farm world.
According to SyrinJector CEO Nahum Cohen: “The current...
Is global climate change affecting fertility?
According to the University of Liverpool, UK, global climate change could make some species sterile and see them succumb earlier than expected.
Published in Trends...
Positive progress in antimicrobial resistance prevention across the globe
Countries are making substantial progress in tackling the ever growing issue of antimicrobial resistance (AMR), however, serious gaps still remain and require urgent action,...
The past, present and future of Wageningen Bioveterinary Research
Dr Riks Maas and Professor Jeroen Kortekaas discuss the pioneering work of Wageningen Bioveterinary Research in the fields of viral vaccine development and animal...
Gene-edited pigs resistant to porcine reproductive & respiratory syndrome
By changing the genetic code of pigs, scientists at the University of Edinburgh's Roslin Institute, UK, have produced animals that can resist one of...
The evolution and spread of antibiotic resistance: A call for more holistic analyses
Antibiotic-resistant bacteria already existed in the environment before antibiotics were used in human medicine.1 Besides promoting the development of new resistance traits, the way...
Duke University creates long-lasting flu vaccine
Duke University researchers have unveiled a promising breakthrough in the ongoing battle against influenza viruses.
Their pioneering research has developed a universal, long-lasting flu vaccine...
Trial demonstrates ARM-002TM vaccine’s effectiveness against pancreatic cancer
Defence Therapeutics has announced a successful pre-clinical vaccination trial utilising its ARM-002TM vaccine against pancreatic cancer.
Search for new type 1 diabetes treatments aided by siblings with genetic change
Two siblings who have the only known mutations in a key gene have helped scientists find potential type 1 diabetes treatments.
The new research, published...
The implications of antibiotic use in farming
Jane Tredgett, Campaigns Manager at Alliance to Save Our Antibiotics, discusses the effects of routine antibiotic use in intensive livestock farming and why it...
BioNxt makes bold move into proprietary MS drug formulation market
Leading bioscience accelerator BioNxt Solutions Inc. is pioneering a cutting-edge oral dissolvable Cladribine product for the treatment of Multiple Sclerosis (MS).
The Company recently acquired...
Regenerative therapies for heart disease
Lorna Rothery spoke to cardiovascular regenerative medicine expert, Professor Paolo Madeddu, who co-led a groundbreaking study that identified a mutant anti-ageing gene that could...
Disease X: Researchers analyse virus ancestry to predict next global pandemic
In the fight against infectious diseases, scientists are digging into the family trees of viruses to predict which one might cause the next big...
Hope vs hype: What has been achieved in tissue engineering and regenerative medicine?
Tissue engineering and organ regeneration expert, Dr Ekaterine Berishvili, discusses the progress, opportunities and challenges of regeneration and repair in organ transplantation.
The growing burden...
Developing mRNA vaccine technology
Following the unprecedented development of vaccines during the COVID-19 pandemic, we spoke to Dinah Knotts about mRNA vaccine technology and what further opportunities it...
Defence Therapeutics granted FDA approval for Phase I Clinical Trial of AccuTOX®
Defence Therapeutics has announced a pivotal milestone: the U.S. Food and Drug Administration (FDA) has granted a green light with a "Study May Proceed"...
Defence Therapeutics applies to use AccuTOX® as an advanced tumour treatment
Defence Therapeutics has submitted an Investigational New Drug application for AccuTOX®, an injectable anticancer molecule.
Accum®-mRNA lipid nanoparticles have double the antibody response of traditional mRNA vaccines
Defence Therapeutics has announced a groundbreaking achievement, demonstrating that its Accum®-mRNA lipid nanoparticles elicit twice the antibody response of mRNA-based vaccines.
The company's encapsulation strategy,...
